Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Detalhes bibliográficos
Principais autores:	Croucher, P, Hijzen, A, Shipman, C, Perry, M, Lippitt, J, Green, J, Van Camp, B, Vanderkerken, K
Formato:	Journal article
Publicado em:	2001

Descrição
Resumo:

Registros relacionados